NCT03270462View on ClinicalTrials.gov

CNS Study of Patients Switching From Tacrolimus to Envarsus

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

May 2, 2020

Study Completion Date

June 2, 2020

Conditions
Renal Transplant Patients
Interventions
DRUG

Envarsus XR

Pilot study documenting the neurotoxic side effects including tremors in patients with stable graft who are receiving Tacrolimus (Envarsus XR) following kidney transplantation. Standardized questionnaire will be used to document these symptoms.

Trial Locations (1)

80045

Lisa Kornfeld, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT03270462 - CNS Study of Patients Switching From Tacrolimus to Envarsus | Biotech Hunter | Biotech Hunter